{'52WeekChange': 1.6291077,
 'SandP52WeekChange': None,
 'address1': '4400 Biscayne Boulevard',
 'algorithm': None,
 'annualHoldingsTurnover': None,
 'annualReportExpenseRatio': None,
 'ask': 5.29,
 'askSize': 1100,
 'averageDailyVolume10Day': 34303350,
 'averageVolume': 16701366,
 'averageVolume10days': 34303350,
 'beta': 2.292436,
 'beta3Year': None,
 'bid': 5.28,
 'bidSize': 45900,
 'bookValue': 2.312,
 'category': None,
 'circulatingSupply': None,
 'city': 'Miami',
 'companyOfficers': [],
 'country': 'United States',
 'currency': 'USD',
 'dateShortInterest': 1593475200,
 'dayHigh': 5.53,
 'dayLow': 5.17,
 'dividendRate': None,
 'dividendYield': None,
 'earningsQuarterlyGrowth': None,
 'enterpriseToEbitda': -63.192,
 'enterpriseToRevenue': 4.3,
 'enterpriseValue': 3831253248,
 'exDividendDate': None,
 'exchange': 'NMS',
 'exchangeTimezoneName': 'America/New_York',
 'exchangeTimezoneShortName': 'EDT',
 'expireDate': None,
 'fiftyDayAverage': 3.4965715,
 'fiftyTwoWeekHigh': 6.47,
 'fiftyTwoWeekLow': 1.12,
 'fiveYearAverageReturn': None,
 'fiveYearAvgDividendYield': None,
 'floatShares': 382150570,
 'forwardEps': 0.04,
 'forwardPE': 132.50002,
 'fromCurrency': None,
 'fullTimeEmployees': 6096,
 'fundFamily': None,
 'fundInceptionDate': None,
 'gmtOffSetMilliseconds': '-14400000',
 'headSymbol': None,
 'heldPercentInsiders': 0.39854,
 'heldPercentInstitutions': 0.26356,
 'industry': 'Diagnostics & Research',
 'isEsgPopulated': False,
 'lastCapGain': None,
 'lastDividendValue': None,
 'lastFiscalYearEnd': 1577750400,
 'lastMarket': None,
 'lastSplitDate': None,
 'lastSplitFactor': None,
 'legalType': None,
 'logo_url': 'https://logo.clearbit.com/opko.com',
 'longBusinessSummary': 'OPKO Health, Inc., a healthcare company, engages in '
                        'the diagnostics and pharmaceuticals businesses in the '
                        'United States, Ireland, Chile, Spain, Israel, Mexico, '
                        "and internationally. The company's Diagnostics "
                        'segment operates BioReference Laboratories, a '
                        'clinical laboratory that offers laboratory testing '
                        'services. The Bio-Reference Laboratories also '
                        'provides core genetic testing and leverage products, '
                        'such as the 4Kscore prostate cancer test. The '
                        "company's Pharmaceutical segment offers Rayaldee for "
                        'treatment for secondary hyperparathyroidism in adults '
                        'with stage 3 or 4 chronic kidney disease, and vitamin '
                        'D insufficiency; OPK88004, a selective androgen '
                        'receptor modulator; and OPK88003, a once or twice '
                        'weekly oxyntomodulin that is in Phase IIb trials for '
                        'type 2 diabetes and obesity. It is also developing '
                        'hGH-CTP, a once-weekly human growth hormone injection '
                        'that completed Phase III clinical trial in '
                        'partnership with Pfizer, Inc.; VARUBI for '
                        'chemotherapy-induced nausea and vomiting; and Factor '
                        'VIIa drug for hemophilia. In addition, this segment '
                        'develops and produces specialty active pharmaceutical '
                        'ingredients; and discovers drugs for the treatment of '
                        'cancer, heart disease, metabolic disorders, and a '
                        'range of genetic anomalies. Further, it develops, '
                        'manufactures, markets, and sells pharmaceutical, '
                        'nutraceutical, and veterinary products; '
                        'commercializes food supplements and over the counter '
                        'products; manufactures and sells products primarily '
                        'in the generics market; and imports, markets, '
                        'distributes, and sells pharmaceutical products in a '
                        'range of indications, including cardiovascular '
                        'products, vaccines, antibiotics, gastro-intestinal '
                        'products, hormones, and others. Additionally, the '
                        'company operates pharmaceutical platforms in Ireland, '
                        'Chile, Spain, and Mexico. OPKO Health, Inc. was '
                        'incorporated in 1991 and is headquartered in Miami, '
                        'Florida.',
 'longName': 'OPKO Health, Inc.',
 'market': 'us_market',
 'marketCap': 3550093824,
 'maxAge': 1,
 'maxSupply': None,
 'messageBoardId': 'finmb_33405327',
 'morningStarOverallRating': None,
 'morningStarRiskRating': None,
 'mostRecentQuarter': 1585612800,
 'navPrice': None,
 'netIncomeToCommon': -293295008,
 'nextFiscalYearEnd': 1640908800,
 'open': 5.46,
 'openInterest': None,
 'payoutRatio': 0,
 'pegRatio': -2.03,
 'phone': '305 575 4100',
 'previousClose': 5.6,
 'priceHint': 2,
 'priceToBook': 2.2923875,
 'priceToSalesTrailing12Months': 3.984616,
 'profitMargins': -0.32919,
 'quoteType': 'EQUITY',
 'regularMarketDayHigh': 5.53,
 'regularMarketDayLow': 5.17,
 'regularMarketOpen': 5.46,
 'regularMarketPreviousClose': 5.6,
 'regularMarketPrice': 5.46,
 'regularMarketVolume': 19863481,
 'revenueQuarterlyGrowth': None,
 'sector': 'Healthcare',
 'sharesOutstanding': 669828992,
 'sharesPercentSharesOut': 0.1933,
 'sharesShort': 129491136,
 'sharesShortPreviousMonthDate': 1590710400,
 'sharesShortPriorMonth': 109535240,
 'shortName': 'Opko Health, Inc.',
 'shortPercentOfFloat': 0.32349998,
 'shortRatio': 9.47,
 'startDate': None,
 'state': 'FL',
 'strikePrice': None,
 'symbol': 'OPK',
 'threeYearAverageReturn': None,
 'totalAssets': None,
 'tradeable': False,
 'trailingAnnualDividendRate': None,
 'trailingAnnualDividendYield': None,
 'trailingEps': -0.483,
 'twoHundredDayAverage': 2.2190647,
 'underlyingExchangeSymbol': None,
 'underlyingSymbol': None,
 'uuid': 'd21495bc-3f90-3f7e-ab0d-a17a57b35371',
 'volume': 19863481,
 'volume24Hr': None,
 'volumeAllCurrencies': None,
 'website': 'http://www.opko.com',
 'yield': None,
 'ytdReturn': None,
 'zip': '33137'}